The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KEYNOTE-859: 4.5-year median follow-up of pembrolizumab plus chemotherapy for previously untreated advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) adenocarcinoma.
 
Sun Young Rha
Consulting or Advisory Role - Amgen; Arcus Biosciences; Astellas Pharma; AstraZeneca; Daiichi Sankyo; Eisai; indivumed; LG Chem; MSD Oncology; Ono Pharmaceutical; Toray Industries
Speakers' Bureau - Amgen; Arcus Biosciences; Astellas Pharma; AstraZeneca; BMS/Ono; Daiichi Sankyo/UCB Japan; Eisai; MSD Oncology
Research Funding - Amgen (Inst); ASLAN Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daichii Sankyo; Eisai; Indivumed; Lilly; MSD Oncology; Roche/Genentech; Sillajen; Zymeworks
 
Lucjan Wyrwicz
Honoraria - BeiGene; BMS; MSD; SERVIER
Consulting or Advisory Role - Agenus; AstraZeneca; GlaxoSmithKline; SERVIER
Speakers' Bureau - BMS; MSD; SERVIER
Travel, Accommodations, Expenses - Amgen; SERVIER
 
Patricio Yanez Weber
Honoraria - AstraZeneca; Bristol-Myers Squibb (Inst); MSD (Inst); Sanofi/Regeneron
Consulting or Advisory Role - AstraZeneca (I); Bristol-Myers Squibb; MSD Oncology
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb
 
Yuxian Bai
No Relationships to Disclose
 
Min-Hee Ryu
Honoraria - Astellas Pharma; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; DAEHWA Pharmaceutical; Daiichi Sankyo; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; DAEHWA Pharmaceutical; Daiichi Sankyo; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); Ono Pharmaceutical (Inst)
 
Jeeyun Lee
Consulting or Advisory Role - Amgen; AstraZeneca; Daichi Sankyo; Guardant Health AMEA; Immunoncia; Mirati Therapeutics; Trutino Biosciences
Research Funding - AstraZeneca; Merck Sharp & Dohme; Samsung Biopeis; Samsung Biopeis
 
Fernando Rivera
Honoraria - BMSi; MSD (Inst); SERVIER
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca Spain; BMSi; MSD
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - MSD
 
Gustavo Alves
Consulting or Advisory Role - AstraZeneca; Merck Serono; MSD Oncology
Speakers' Bureau - AstraZeneca; GlaxoSmithKline; Sanofi
Research Funding - AstraZeneca (Inst); AVEO (Inst); BeiGene (Inst); BMS Brazil (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Roche (Inst); Sanofi (Inst); Zymeworks (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
Marcelo Garrido
Consulting or Advisory Role - AstraZeneca; MSD; Roche
Speakers' Bureau - Bayer; Bristol-Myers Squibb; MERCK
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Roche
 
Kai-Keen Shiu
Honoraria - Bayer; Bristol-Myers Squibb; Merck Serono; MSD Oncology; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Mirati Therapeutics; MSD Oncology; Nouscom; Roche; Seagen; Takeda
Research Funding - AstraZeneca (Inst); BioNTech SE (Inst); MSD Oncology (Inst); Nouscom (Inst); Roche (Inst)
 
Manuel González Fernández
No Relationships to Disclose
 
Jin Li
No Relationships to Disclose
 
Maeve Lowery
Consulting or Advisory Role - AstraZeneca; Roche/Genentech; SERVIER
Research Funding - Astellas Pharma (Inst); Basilea (Inst); Exelixis (Inst); Genuity Science (Inst); Legend Biotech (Inst); MSD (Inst); Zymeworks (Inst)
 
Timucin Cil
Consulting or Advisory Role - AstraZeneca; BMS Turkey; Merck
Speakers' Bureau - Lilly; Pfizer; Takeda
 
Felipe Cruz
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Pfizer
Travel, Accommodations, Expenses - Janssen Oncology; Novartis
 
Do-Youn Oh
Consulting or Advisory Role - Abbvie; Alligtor Bioscience AB; Arcus Biosciences; ASLAN Pharmaceuticals; Astellas Pharma; AstraZeneca; Basilea; Bayer; BeiGene; Celgene; Eutilex; Genentech/Roche; Halozyme; Hana Pharm; Idience; IQVIA; J-Pharma; LG Chem; Merck Serono; Mirati Therapeutics; Moderna Therapeutics; MSD Oncology; Novartis; Taiho Pharmaceutical; Turning Point Therapeutics; Yuhan; Zymeworks
Research Funding - Array BioPharma; AstraZeneca; BeiGene; Handok; Lilly; MSD; Novartis; SERVIER
 
Pierre LeConte
Employment - MSD Oncology
Travel, Accommodations, Expenses - MSD Oncology
 
Pooja Bhagia
Employment - Merck
 
Shukui Qin
No Relationships to Disclose